Lacosamide Effects on Alcohol Self Administration and Craving in Heavy Drinkers

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

April 15, 2018

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Alcohol Use Disorder
Interventions
DRUG

Lacosamide

Lacosamide titration was done to a target dose of 300mg. Participants took 100 mg of lacosamide once on day 1, 100 mg twice per day from day 2 through day 6 (200 mg daily total), on day 7 the lacosamide dose was increased to 150 mg twice daily (300 mg daily total), and on day 8 the participant took one dose of 150 mg.

DRUG

Placebo oral capsule

Participants took a placebo oral capsule once on day 1, twice per day from day 2 to day 7, and once on day 8.

Trial Locations (1)

02118

Boston University Psychiatry Research Center, Clinical Studies Unit, Boston

Sponsors
All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Boston Medical Center

OTHER